Jane Street Group LLC Has $70,000 Holdings in Aemetis, Inc. (NASDAQ:AMTX)

Jane Street Group LLC lessened its stake in shares of Aemetis, Inc. (NASDAQ:AMTXFree Report) by 18.4% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 30,407 shares of the specialty chemicals company’s stock after selling 6,856 shares during the quarter. Jane Street Group LLC’s holdings in Aemetis were worth $70,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. State Street Corp boosted its position in shares of Aemetis by 36.1% in the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after acquiring an additional 185,304 shares during the period. Susquehanna Fundamental Investments LLC boosted its holdings in shares of Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Aemetis in the second quarter valued at about $306,000. Wellington Management Group LLP acquired a new position in Aemetis during the 3rd quarter worth approximately $177,000. Finally, Rhumbline Advisers increased its holdings in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares in the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently issued reports on AMTX shares. StockNews.com upgraded shares of Aemetis to a “sell” rating in a report on Friday, January 3rd. HC Wainwright restated a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Read Our Latest Report on Aemetis

Aemetis Price Performance

Shares of NASDAQ:AMTX opened at $2.80 on Thursday. Aemetis, Inc. has a one year low of $2.10 and a one year high of $7.03. The firm has a fifty day moving average price of $3.27 and a two-hundred day moving average price of $2.96. The company has a market cap of $139.26 million, a price-to-earnings ratio of -1.24 and a beta of 1.47.

Aemetis (NASDAQ:AMTXGet Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period in the previous year, the company earned ($0.59) EPS. Equities research analysts expect that Aemetis, Inc. will post -2.02 EPS for the current fiscal year.

Aemetis Profile

(Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Featured Articles

Want to see what other hedge funds are holding AMTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aemetis, Inc. (NASDAQ:AMTXFree Report).

Institutional Ownership by Quarter for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.